Change in the use of Renin-Angiotensin System Blockers in Older Patients Fulfilling the HOPE Criteria

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Sumukadas, D.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Sumukadas, D.


Social Bookmarking

	What's this?

Deepa Sumukadas

University of Dundee, Ninewells Hospital and Medical School, Dundee, d.sumukadus{at}dundee.ac.uk

Key Words: Aged • Cardiovascular • Prescribing

References

Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]

Leu HB, Charng MJ, Ding PY A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension. Jpn Heart J 2004;45:623-35.[CrossRef][Medline] [Order article via Infotrieve]

Pitt B., Poole-Wilson P., Segal R. et al. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study-ELITE II. J Card Fail 1999;5:146-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sleight P. The ONTARGET/TRANSCEND Trial Programme: baseline data. ActaDiabetol 2005;42(Suppl 1):S50-S56.

Sumukadas D., Witham MD, Struthers AD, McMurdo ME Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors? JRAAS 2004;5:26.[Medline] [Order article via Infotrieve]